India's pharmaceutical industry: globalization, competition and financialization

This book contributes to the analysis of pharmaceutical companies with a threefold purpose. On the one hand, it attempts to demonstrate the relevance of the capitalist pharmaceutical company in a competitive and globalized environment. On the other hand, it develops the structure in which this type of company fits in contemporary conditions. Finally, it provides an overview of the finances of Indian pharmaceutical companies in this context. Through five sections, the author clearly reflects the analytical and interpretative framework he uses to reveal the current state of India's five largest pharmaceutical companies. Sosa analyzes the cases of Sun Pharmaceutical Industries Ltd., Lupin Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd. and Aurobindo Pharma Ltd. as he considers them as a representative sample of the overall picture of the economic functioning of the pharmaceutical company in this region. In this way, the book is a study not only of a financial nature, but also of a historical and systematic nature that deals with the functioning of pharmaceutical corporations participating in the phenomenon of globalization and financialization.

2022 | Ciudad de México | 247 pages

ISBN Electrónico: 978-607-30-5573-4 PDF / 978-607-30-8536-6 EPUB